BioSpace News Archive

MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, announced the hiring of Joyce Rico, MD, MBA, FAAD, as Chief Medical Officer.

Annexon, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, announced fourth quarter and full-year 2020 financial results and business highlights.

Goal is to generate proof of principle and mechanistic understanding of the efficacy of antibodies targeting IL-11 receptor in idiopathic pulmonary fibrosis

Supported by a $150 million endowment from Eric and Wendy Schmidt, the center will create a new field of interdisciplinary research aimed at improving human health.

Anthony Zolezzi, CEO of Diomics Corporation, is pleased to welcome Bill Nicholson to the Diomics Corporation Board.

Company Focuses on Sustainable Environmental, Health and Safety Performance, and Advancing Diversity and Inclusion

Company affirms position as the largest wholesaler of branded products in the industry with $274.0 million in wholesale revenue for the year

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Sara Toyloy has joined its Board of Directors and will serve on Shockwave’s Audit Committee.

- Completed $25 Million Strategic Financing; Extending Cash Runway into 2023 - Accelerated Development of AL102 Desmoid Tumor Program into Phase 2/3 Pivotal Trial - On Track to Report Multiple Milestones in 2021 Across Clinical-Stage Pipeline

WAKIX ® (pitolisant) Total Revenue of $160 Million for Full-Year 2020 ; $56 Million for Fourth Quarter 2020 Clinical Utility of WAKIX was Expanded with Additional Approval for Treatment of Cataplexy in Adults with Narcolepsy Enrollment Continues in Phase 2 Trial of Patients with Prader-Willi Syndrome On Track to Initiate Two Additional Clinical Trials with Pitolisant in 2021 Conference Call and Webcast to be Held Today at 8:30 a.m. ET